Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial.
Tremblay S, Alhogbani M, Weickhardt A, Davis ID, Scott AM, Hicks RJ, Metser U, Chua S, Davda R, Punwani S, Payne H, Tunariu N, Ho B, Young S, Singbo MNU, Bauman G, Emmett L, Pouliot F. Tremblay S, et al. Among authors: payne h. Cancer Imaging. 2023 Jun 8;23(1):57. doi: 10.1186/s40644-023-00570-x. Cancer Imaging. 2023. PMID: 37291656 Free PMC article.
Hormone therapy for radiorecurrent prostate cancer.
Payne H, Khan A, Chowdhury S, Davda R. Payne H, et al. World J Urol. 2013 Dec;31(6):1333-8. doi: 10.1007/s00345-012-0952-8. Epub 2012 Sep 21. World J Urol. 2013. PMID: 22996761 Review.
Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach.
Morgans AK, van Bommel AC, Stowell C, Abrahm JL, Basch E, Bekelman JE, Berry DL, Bossi A, Davis ID, de Reijke TM, Denis LJ, Evans SM, Fleshner NE, George DJ, Kiefert J, Lin DW, Matthew AG, McDermott R, Payne H, Roos IA, Schrag D, Steuber T, Tombal B, van Basten JP, van der Hoeven JJ, Penson DF; Advanced Prostate Cancer Working Group of the International Consortium for Health Outcomes Measurement. Morgans AK, et al. Among authors: payne h. Eur Urol. 2015 Nov;68(5):891-8. doi: 10.1016/j.eururo.2015.06.007. Epub 2015 Jun 28. Eur Urol. 2015. PMID: 26129856 Free article.
Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer.
Davda R, Hughes S, Jones R, Crabb SJ, Troup J, Payne H. Davda R, et al. Among authors: payne h. Clin Oncol (R Coll Radiol). 2016 Jun;28(6):376-85. doi: 10.1016/j.clon.2016.01.006. Epub 2016 Feb 11. Clin Oncol (R Coll Radiol). 2016. PMID: 26874654 Free article. Afrikaans, English.
Transperineal Magnetic Resonance Imaging-targeted Biopsy versus Transperineal Template Prostate Mapping Biopsy in the Detection of Localised Radio-recurrent Prostate Cancer.
Kanthabalan A, Abd-Alazeez M, Arya M, Allen C, Freeman A, Jameson C, Kirkham A, Mitra AV, Payne H, Punwani S, Ramachandran N, Walkden M, Emberton M, Ahmed HU. Kanthabalan A, et al. Among authors: payne h. Clin Oncol (R Coll Radiol). 2016 Sep;28(9):568-76. doi: 10.1016/j.clon.2016.04.038. Epub 2016 Jun 16. Clin Oncol (R Coll Radiol). 2016. PMID: 27318423
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey.
Lorente D, Ravi P, Mehra N, Pezaro C, Omlin A, Gilman A, Miranda M, Rescigno P, Kolinsky M, Porta N, Bianchini D, Tunariu N, Perez R, Mateo J, Payne H, Terstappen L, IJzerman M, Hall E, de Bono J. Lorente D, et al. Among authors: payne h. Eur Urol Focus. 2018 Mar;4(2):235-244. doi: 10.1016/j.euf.2016.09.005. Epub 2016 Oct 10. Eur Urol Focus. 2018. PMID: 28753792 Free article.
Toxicity Outcomes in the Elderly Prostate Cancer Patient.
Prentice M, Davda R, Nuhoglu Savas A, Payne H. Prentice M, et al. Among authors: payne h. Clin Oncol (R Coll Radiol). 2018 Jan;30(1):e37. doi: 10.1016/j.clon.2017.10.018. Epub 2017 Nov 20. Clin Oncol (R Coll Radiol). 2018. PMID: 29157797 No abstract available.
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ; ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Davis ID, et al. N Engl J Med. 2019 Jul 11;381(2):121-131. doi: 10.1056/NEJMoa1903835. Epub 2019 Jun 2. N Engl J Med. 2019. PMID: 31157964 Clinical Trial.
411 results